Latest News & Updates of Loncom Pharma

Shandong Loncom Pharmaceutical Co., Ltd. has achieved a major regulatory milestone by obtaining the Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its Sorafenib Tosylate active pharmaceutical ingredient (API). This accomplishment h

IntroductionIn the realm of pharmaceutical advancements, the development of effective and safe active pharmaceutical ingredients (APIs) is crucial for improving patient outcomes. Among the latest innovations, Linzagolix Choline has emerged as a promising API, particularly in the treatment of endomet

Season's Greetings from Shandong Loncom Pharmaceutical As we reflect on a year full of achievements and collaborations, we want to extend our warmest wishes to all of our valued partners. Your trust and support have been vital in helping us advance our mission to improve women's health worldwide.Mer

As we usher in the auspicious Year of the Dragon, we extend our heartfelt greetings and best wishes to you and your team. May this new lunar year bring you good health, success in your endeavors, and continuous prosperity.We are pleased to inform you that our operations have resumed to normal and ou